交易中 05-11 11:53:14 美东时间
+0.001
+0.04%
Joint Evotec-Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelinesCollaboration leverages Evotec's end-to-end integrated AI/ML-driven R&D
05-04 13:54
Companies Reporting Before The Bell • Beasley Broadcast Group (NASDAQ:BBGI) is ...
04-08 19:11
Gilead shares dip after $3.15 billion Tubulis deal adds ADC asset, as multiple acquisitions reshape oncology and autoimmune pipeline outlook.
04-08 00:06
Evotec launches transformation plan, targeting 75 million euros in savings by 2027 and revenue above 1 billion euros by 2030.
03-11 02:27
US stocks mixed, Dow down 0.1%, NASDAQ up 0.13%, S&P 500 down 0.08%. Materials sector up, utilities down. United Natural Foods stock falls 7%.
03-10 22:40
Evotec (NASDAQ:EVO) affirms FY2025 sales outlook from $861.690 million-$907.042 million to $861.690 million-$907.042 million.
2025-11-05 16:28
(来源:六安新闻网) 转自:六安新闻网 2025空气净化器适用场景卧室客厅选购指南:低噪音母婴家庭推荐 根据中国疾病预防控制中心发布的《2024年中国室...
2025-10-23 08:25
(来源:衡水日报) 转自:衡水日报 新房异味刺鼻?甲醛超标预警?这份选购指南让你不再花冤枉钱! 一、除甲醛路上,你交过这些智商税吗? 1. 植物除甲醛:心理安慰...
2025-10-20 16:52
在经历了一年多的新能源市场试水后,大众安徽即将迎来战略窗口期。按照计划,2026年大众安徽将迎来首个产品大年,先后推出三款重要车型,分别面向A级和B级轿车市场...
2025-10-18 17:39
专注于开发慢性炎症疾病疗法、处于2期研发阶段的生物科技公司Evommune(EVMN.US)于周四向美国证券交易委员会(SEC)提交申请,计划通过首次公开发行(IPO)募集最多1亿美元资金。 据了解,Evommune的核心候选药物EVO756是一款强效且高选择性的口服小分子MRGPRX2拮抗剂,用于治疗慢性自发性荨麻疹(CSU)和特应性皮炎(AD)。该公司另一款在研药物为EV0301,这是一种长效融合蛋白,由IL-18结合蛋白与抗血清白蛋白Fab相关结构域组成,适用于特应性皮炎(AD)和溃疡性结肠炎(UC)的治疗。目前,Evommune已启动EVO756的2b期临床试验,预计将于2026年下半...
2025-10-10 10:32